Gianni Tognoni Selected Research

Valsartan (Vals)

11/2013	Incidence of atrial fibrillation in a population with impaired glucose tolerance: the contribution of glucose metabolism and other risk factors. A post hoc analysis of the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research trial.
11/2013	Interaction between baseline and early worsening of renal function and efficacy of renin-angiotensin-aldosterone system blockade in patients with heart failure: insights from the Val-HeFT study.
9/2013	Predictors of stroke in patients with impaired glucose tolerance: results from the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research trial.
3/2013	Predictors of incident heart failure hospitalizations among patients with impaired glucose tolerance: insight from the Nateglinide And Valsartan in Impaired Glucose Tolerance Outcomes Research study.
1/2012	Serial measurement of cardiac troponin T using a highly sensitive assay in patients with chronic heart failure: data from 2 large randomized clinical trials.
1/2012	Predictors of cardiovascular events in a contemporary population with impaired glucose tolerance: an observational analysis of the Nateglinide and Valsartan in impaired glucose tolerance outcomes research (NAVIGATOR) trial.
11/2011	Left atrial remodeling and response to valsartan in the prevention of recurrent atrial fibrillation: the GISSI-AF echocardiographic substudy.
12/2010	Elevated plasma renin activity predicts adverse outcome in chronic heart failure, independently of pharmacologic therapy: data from the Valsartan Heart Failure Trial (Val-HeFT).
4/2010	Effect of nateglinide on the incidence of diabetes and cardiovascular events.
4/2010	Effect of valsartan on the incidence of diabetes and cardiovascular events.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gianni Tognoni Research Topics

Disease

55	Heart Failure 09/2021 - 10/2002
27	Myocardial Infarction 01/2017 - 04/2002
23	Atrial Fibrillation 11/2021 - 03/2005
17	Cardiovascular Diseases (Cardiovascular Disease) 01/2018 - 12/2003
13	Sepsis (Septicemia) 12/2018 - 05/2003
13	Stroke (Strokes) 01/2017 - 01/2003
10	Septic Shock (Toxic Shock Syndrome) 12/2018 - 01/2014
9	Type 2 Diabetes Mellitus (MODY) 01/2018 - 12/2003
9	Hemorrhage 01/2018 - 01/2004
8	Polycythemia Vera 12/2022 - 01/2003
8	Hypertension (High Blood Pressure) 11/2013 - 12/2002
7	Diabetes Mellitus 01/2018 - 08/2007
6	Chronic Obstructive Pulmonary Disease (COPD) 01/2019 - 09/2006
6	Glucose Intolerance 11/2013 - 04/2010
5	Thrombosis (Thrombus) 11/2017 - 01/2003
5	Neoplasms (Cancer) 10/2016 - 08/2005
5	Sudden Death 12/2007 - 04/2002
4	Chronic Kidney Failure (Chronic Renal Failure) 12/2018 - 07/2010
4	Left Ventricular Dysfunction 01/2018 - 08/2005
4	Coronary Disease (Coronary Heart Disease) 09/2013 - 04/2002
3	Shock 01/2018 - 04/2016
3	Pain (Aches) 10/2016 - 04/2007
3	Inflammation (Inflammations) 05/2015 - 06/2012
3	Body Weight (Weight, Body) 04/2015 - 11/2013
3	Pulmonary Arterial Hypertension 01/2014 - 02/2010
3	Vascular Diseases (Vascular Disease) 01/2013 - 01/2005
3	Acute Coronary Syndrome 03/2012 - 09/2002
3	Unstable Angina 04/2010 - 09/2002
2	Albuminuria 12/2018 - 01/2010
2	Drug-Related Side Effects and Adverse Reactions 11/2018 - 09/2002
2	Thrombocytopenia (Thrombopenia) 01/2018 - 01/2003
2	Anemia 01/2017 - 01/2003
2	Pressure Ulcer (Bedsore) 07/2016 - 04/2010
2	Infarction (Infarctions) 01/2013 - 05/2004
2	Chronic Renal Insufficiency 03/2012 - 07/2010
2	Coronary Artery Disease (Coronary Atherosclerosis) 01/2012 - 04/2003
2	Atrial Remodeling 11/2011 - 04/2009
2	Cardiac Arrhythmias (Arrythmia) 07/2011 - 04/2009
2	Hypoxia (Hypoxemia) 04/2010 - 11/2009
2	Pulmonary Hypertension 02/2010 - 06/2007
2	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 10/2008 - 10/2008
2	Atherosclerosis 03/2008 - 05/2004
2	Hypotension (Low Blood Pressure) 01/2008 - 12/2002

Drug/Important Bio-Agent (IBA)

24	Valsartan (Vals)FDA Link 11/2013 - 10/2002
17	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2018 - 09/2002
15	AlbuminsIBA 01/2020 - 01/2010
14	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 01/2016 - 04/2002
14	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 11/2013 - 04/2002
12	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 06/2015 - 06/2007
10	Brain Natriuretic Peptide (Natrecor)FDA Link 04/2016 - 11/2002
9	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 12/2018 - 10/2002
8	Biomarkers (Surrogate Marker)IBA 11/2021 - 10/2004
8	CreatinineIBA 01/2020 - 06/2006
7	Rosuvastatin Calcium (Crestor)FDA Link 12/2015 - 08/2004
6	pro-brain natriuretic peptide (1-76)IBA 11/2021 - 10/2004
6	Troponin T (Troponin T1)IBA 02/2019 - 09/2007
6	Insulin (Novolin)FDA Link 01/2018 - 04/2003
6	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 05/2005
6	Nateglinide (Starlix)FDA LinkGeneric 11/2013 - 04/2010
5	Pharmaceutical PreparationsIBA 11/2017 - 04/2002
5	Biological ProductsIBA 01/2017 - 04/2010
5	CholesterolIBA 01/2012 - 04/2003
5	Neurotransmitter Agents (Neurotransmitter)IBA 06/2006 - 11/2002
4	Angiotensin Receptor AntagonistsIBA 12/2018 - 10/2002
4	LDL CholesterolIBA 01/2015 - 08/2007
3	Indicators and Reagents (Reagents)IBA 01/2020 - 09/2007
3	Uric Acid (Urate)IBA 01/2019 - 07/2013
3	TroponinIBA 01/2018 - 01/2012
3	Peptides (Polypeptides)IBA 01/2017 - 06/2006
3	Analgesics (Analgesic Drugs)IBA 10/2016 - 04/2007
3	Lipopolysaccharide ReceptorsIBA 09/2015 - 01/2014
3	Fish OilsIBA 02/2015 - 03/2009
3	LipidsIBA 01/2015 - 01/2005
3	Hemoglobins (Hemoglobin)IBA 01/2013 - 01/2007
3	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2013 - 03/2012
3	Vasodilator Agents (Vasodilators)IBA 09/2011 - 10/2002
3	Lisinopril (Prinivil)FDA LinkGeneric 02/2008 - 12/2002
3	DiureticsIBA 09/2007 - 09/2002
2	Hydroxyurea (Hydrea)FDA LinkGeneric 12/2022 - 11/2017
2	Coffee FDA Link 09/2021 - 12/2007
2	Oxygen (Dioxygen)IBA 12/2018 - 04/2010
2	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 12/2018 - 10/2002
2	HematinicsIBA 01/2017 - 07/2010
2	PTX3 proteinIBA 01/2017 - 05/2015
2	Morphine (MS Contin)FDA LinkGeneric 10/2016 - 04/2007
2	Opioid Analgesics (Opioids)IBA 10/2016 - 04/2007
2	EstersIBA 01/2016 - 03/2009
2	AcidsIBA 01/2016 - 11/2013
2	OsteoprotegerinIBA 05/2015 - 08/2010
2	insulin receptor-related receptor (IRR)IBA 01/2015 - 06/2012
2	Clopidogrel (Plavix)FDA Link 03/2012 - 09/2002
2	HDL CholesterolIBA 01/2012 - 03/2006

Therapy/Procedure

26	Therapeutics 12/2022 - 01/2003
4	Resuscitation 12/2018 - 10/2002
4	Electric Countershock (Cardioversion) 11/2012 - 01/2006
2	Drug Therapy (Chemotherapy) 11/2018 - 01/2003
2	Secondary Prevention 01/2018 - 02/2012
2	Renal Dialysis (Hemodialysis) 01/2017 - 01/2013
2	Percutaneous Coronary Intervention 09/2015 - 03/2012
2	Artificial Respiration (Mechanical Ventilation) 07/2014 - 11/2009